Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it? | Intensive Care Med;43(4): 578-580, 2017 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it?

Prowle, J R; Schetz, M.

Affiliation

Prowle JR; Adult Critical Care Unit and Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK. j.prowle@qmul.ac.uk.
Schetz M; William Harvey Research Institute, Queen Mary University of London, London, UK. j.prowle@qmul.ac.uk.

Intensive Care Med ; 43(4): 578-580, 2017 04.

Article in En | MEDLINE | ID: mdl-28210773

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Acute Kidney Injury Limits: Humans Language: En Journal: Intensive Care Med Year: 2017 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Acute Kidney Injury Limits: Humans Language: En Journal: Intensive Care Med Year: 2017 Document type: Article Country of publication: